Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results.

Publication Title

Arthritis Rheumatol

Authors

Philip MeaseFollow

Document Type

Article

Publication Date

2-1-2019

Clinical Institute

Orthopedics & Sports Medicine

Specialty/Research Institute

Orthopedics

Specialty/Research Institute

Rheumatology